PL166094B1 - Sposób wytwarzania wodzianu 6-cykloheksylo-2’-0-metylo-adenozyny PL - Google Patents

Sposób wytwarzania wodzianu 6-cykloheksylo-2’-0-metylo-adenozyny PL

Info

Publication number
PL166094B1
PL166094B1 PL91292665A PL29266591A PL166094B1 PL 166094 B1 PL166094 B1 PL 166094B1 PL 91292665 A PL91292665 A PL 91292665A PL 29266591 A PL29266591 A PL 29266591A PL 166094 B1 PL166094 B1 PL 166094B1
Authority
PL
Poland
Prior art keywords
adenosine
methyl
cyclohexyl
hydrate
production
Prior art date
Application number
PL91292665A
Other languages
English (en)
Polish (pl)
Other versions
PL292665A1 (en
Inventor
Fulvio Gadient
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PL292665A1 publication Critical patent/PL292665A1/xx
Publication of PL166094B1 publication Critical patent/PL166094B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL91292665A 1990-12-07 1991-12-06 Sposób wytwarzania wodzianu 6-cykloheksylo-2’-0-metylo-adenozyny PL PL166094B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4039060A DE4039060A1 (de) 1990-12-07 1990-12-07 Neue kristallform

Publications (2)

Publication Number Publication Date
PL292665A1 PL292665A1 (en) 1992-12-14
PL166094B1 true PL166094B1 (pl) 1995-03-31

Family

ID=6419797

Family Applications (1)

Application Number Title Priority Date Filing Date
PL91292665A PL166094B1 (pl) 1990-12-07 1991-12-06 Sposób wytwarzania wodzianu 6-cykloheksylo-2’-0-metylo-adenozyny PL

Country Status (9)

Country Link
DE (1) DE4039060A1 (OSRAM)
FI (1) FI915734L (OSRAM)
IL (1) IL100241A (OSRAM)
NO (1) NO178545C (OSRAM)
NZ (1) NZ240873A (OSRAM)
PL (1) PL166094B1 (OSRAM)
SG (1) SG44937A1 (OSRAM)
TW (1) TW224050B (OSRAM)
ZA (1) ZA919658B (OSRAM)

Also Published As

Publication number Publication date
NO178545C (no) 1996-04-17
NZ240873A (en) 1993-09-27
FI915734A7 (fi) 1992-06-08
IL100241A0 (en) 1992-09-06
TW224050B (OSRAM) 1994-05-21
DE4039060A1 (de) 1992-06-11
FI915734A0 (fi) 1991-12-05
SG44937A1 (en) 1997-12-19
ZA919658B (en) 1993-06-27
NO914779L (no) 1992-06-09
NO178545B (no) 1996-01-08
PL292665A1 (en) 1992-12-14
IL100241A (en) 1995-12-08
FI915734L (fi) 1992-06-08
NO914779D0 (no) 1991-12-05

Similar Documents

Publication Publication Date Title
KR0137786B1 (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
JPH0261477B2 (OSRAM)
EP0490818B1 (en) 6-cyclohexyl-2'-0-methyl-adenosine hydrate and uses thereof
JP2002537258A (ja) 高血圧の治療のための医薬
JPS5869812A (ja) 血糖降下剤
WO2000043392A2 (de) Verwendung von imidazo[1,5-a]-pyrido[3,2-e]-pyrazinonen als arzneimittel
FI91964B (fi) Menetelmä uusien, farmaseuttisesti aktiivisten 1-(hydroksistyryyli)-5H-2,3-bentsodiatsepiinijohdannaisten valmistamiseksi
US3823234A (en) Monohydrated papaverine adenosine-5'-monophosphate medicament for treatment of cardiovascular disorders
US4600710A (en) β-Adrenergic receptor agonist alkylaminoalkyl pyridinemethanol derivatives
FI66598C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara sapetersyraestrar av n-(hydroxialkyl)pyridinkarboxamidderiv at
WO1994005290A1 (fr) Inhibiteur d'agregation plaquettaire
PL166094B1 (pl) Sposób wytwarzania wodzianu 6-cykloheksylo-2’-0-metylo-adenozyny PL
DE2610985A1 (de) Arzneimittel enthaltend beta-d-1 (6-amino-9h-purin-9-yl)-1-deoxyribofuranuronsaeurederivate
JPS61122275A (ja) 新規ヒダントイン誘導体及び該化合物を含有する医薬組成物
JPH01503456A (ja) 6‐(6‐アルキルピリドン)‐カルボスチリル化合物およびそれらの強心薬用法
SK146096A3 (en) Adenosine derivatives, processes for their preparation, their use for the preparation of drugs, their use in therapy and pharmaceutical compositions containing them
JP3024789B2 (ja) 血圧降下剤
JPH0339513B2 (OSRAM)
JPS63208525A (ja) 心不全治療剤
JP2756941B2 (ja) 2−クロロ−3−アリールアミノ−1,4−ナフトキノン誘導体の血小板凝集抑制剤としての用途
HRP920648A2 (en) New crystalline form
JPH0361646B2 (OSRAM)
US3974164A (en) Reserpic acid derivatives
Worcel Mechanism of action of hydralazine and ISF 2123 on arterial smooth muscle [proceedings]
WO1997028803A1 (en) Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits